Medpace
MEDP
144 hedge funds and large institutions have $612M invested in Medpace in 2018 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 61 increasing their positions, 25 reducing their positions, and 8 closing their positions.
413% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 8
144% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 25
83% more capital invested
Capital invested by funds: $335M → $612M (+$277M)
27% more funds holding
Funds holding: 113 → 144 (+31)
13.01% more ownership
Funds ownership: 27.04% → 40.06% (+13%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCM
Laurion Capital Management
New York
|
+$27.5M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$21.6M |
| 3 |
BlackRock
New York
|
+$15.9M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$11.4M |
| 5 |
CIP
Chartwell Investment Partners
Berywn,
Pennsylvania
|
+$10.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCA
Bernzott Capital Advisors
Camarillo,
California
|
-$8.29M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$3.14M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$1.68M |
| 4 |
VRS
Virginia Retirement Systems
Richmond,
Virginia
|
-$1.59M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$1.53M |
MEDP Hedge Fund Activity: Q2 2018 in Review
144 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q2 2018, worth a combined $612M — up 83% from $335M a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new MEDP positions and 8 closed out — a net gain of 33 holders — while 61 added to existing stakes and 25 trimmed.
The largest buyer was Laurion Capital Management, opening a new position worth an estimated $27.5M. The largest seller was Bernzott Capital Advisors, cutting an estimated $8.29M.
- 144 institutional investors held Medpace (MEDP) as of Q2 2018, up from 113 in Q1 2018.
- Funds reported $612M of Medpace stock for Q2 2018, up 83% quarter-over-quarter.
- 41 funds opened new Medpace positions in Q2 2018 and 8 closed out, a net change of +33 holders.
- The largest Medpace buyer in Q2 2018 was Laurion Capital Management, an estimated $27.5M added.
- The largest Medpace seller in Q2 2018 was Bernzott Capital Advisors, an estimated $8.29M sold.
Based on aggregated 13F filings for Q2 2018.